Andrew Casey

President & CEO of BIOTECanada

Andrew Casey became president and CEO of BIOTECanada in August, 2012. In his role as President & CEO of BIOTECanada Andrew is responsible for the strategic operations of the Association which represents Canada’s biotechnology sector. As the head of BIOTECanada, he is the lead spokesperson for Canada’s biotechnology industry communicating on the industry’s behalf with government, regulators, international bodies, media and the Canadian public. Prior to joining BIOTECanada, Andrew served from 2004-2012 as Vice President, Public Affairs and International Trade with the Forest Products Association of Canada.

CLINICAL TRIALS ONTARIO

Clinical Trials Ontario is a leading organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials. We work collaboratively with industry, research institutes, patients and the public and other health innovation organizations to improve the clinical trials environment and attract investment to the province, while supporting the highest ethical and quality standards.